LINQ® Procedure vs. Conventional Medical Management for Sacroiliac Dysfunction
LINQT: An Open Label Randomized, Controlled, Multicenter, Prospective, Long Term Clinical Study on the Minimally Invasive Posterior Sacroiliac Fusion Device LINQ® System
PainTEQ, LLC
200 participants
Jul 1, 2026
INTERVENTIONAL
Conditions
Summary
The objective of this clinical evaluation is to assess the safety and effectiveness of LINQ fusion procedure for treatment of sacroiliac joint (SIJ) dysfunction compared to Conservative Medical Management (CMM).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The LINQ system is intended for use in patients with SIJ disease by implantation of compatible implants to prepare the SIJ for allograft fusion.
CMM Control Arm shall receive standardized, stepwise, non-surgical management for SIJ pain.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07558278